Statistics

Total Visits

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice33

Select a period of time:

Number of views in the range

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice20

Views

Views
January 20250
February 20250
March 202515
April 20253
May 20252
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States3
Brazil1
Spain1
 

Top cities views

Views
Council Bluffs1
Houston1
Mantena1